EPHEDRINE SULFATE
| Brand name | EMERPHED |
|---|---|
| Active ingredient | EPHEDRINE SULFATE |
| Strength | 50MG/10ML (5MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | April 2020 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11478436 | May 2040 | use U-3183 |
| 11090278 | May 2040 | use U-3183 |
| 11571398 | May 2040 | use U-3183 |
| 11241400 | May 2040 | use U-3183 |
| 11464752 | May 2040 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.